These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26296210)

  • 1. Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases.
    Evans-Marin HL; Cong Y
    Inflamm Allergy Drug Targets; 2015; 14(1):4-12. PubMed ID: 26296210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to MAdCAM-1 in Human T Cells.
    Wendt E; White GE; Ferry H; Huhn M; Greaves DR; Keshav S
    J Immunol; 2016 May; 196(9):3910-9. PubMed ID: 27016601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Generation of Gut-Homing Regulatory T Cells for the Suppression of Colitis.
    Xu Y; Cheng Y; Baylink DJ; Wasnik S; Goel G; Huang M; Cao H; Qin X; Lau KW; Chan C; Koch A; Pham LH; Zhang J; Li CH; Wang X; Berumen EC; Smith J; Tang X
    J Immunol; 2019 Jun; 202(12):3447-3457. PubMed ID: 31053627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRAK1 Drives Intestinal Inflammation by Promoting the Generation of Effector Th Cells with Optimal Gut-Homing Capacity.
    Heiseke AF; Jeuk BH; Markota A; Straub T; Lehr HA; Reindl W; Krug AB
    J Immunol; 2015 Dec; 195(12):5787-94. PubMed ID: 26561545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Heteromeric Complex Formed by Dopamine Receptor D
    Osorio-Barrios F; Navarro G; Campos J; Ugalde V; Prado C; Raïch I; Contreras F; López E; Espinoza A; Lladser A; Franco R; Pacheco R
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):489-506. PubMed ID: 33864900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of gut-homing receptors on circulating B cells during infancy.
    Lundell AC; Rabe H; Quiding-Järbrink M; Andersson K; Nordström I; Adlerberth I; Wold AE; Rudin A
    Clin Immunol; 2011 Jan; 138(1):97-106. PubMed ID: 21075690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.
    Mann ER; McCarthy NE; Peake ST; Milestone AN; Al-Hassi HO; Bernardo D; Tee CT; Landy J; Pitcher MC; Cochrane SA; Hart AL; Stagg AJ; Knight SC
    Clin Exp Immunol; 2012 Nov; 170(2):122-30. PubMed ID: 23039882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease.
    Lamb CA; O'Byrne S; Keir ME; Butcher EC
    J Crohns Colitis; 2018 Aug; 12(suppl_2):S653-S668. PubMed ID: 29767705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice.
    Cassani B; Villablanca EJ; Quintana FJ; Love PE; Lacy-Hulbert A; Blaner WS; Sparwasser T; Snapper SB; Weiner HL; Mora JR
    Gastroenterology; 2011 Dec; 141(6):2109-18. PubMed ID: 21925467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential T cell homing to colon vs. small intestine is imprinted by local CD11c
    Dzutsev A; Hogg A; Sui Y; Solaymani-Mohammadi S; Yu H; Frey B; Wang Y; Berzofsky JA
    J Leukoc Biol; 2017 Dec; 102(6):1381-1388. PubMed ID: 28951425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.
    Jovani M; Danese S
    Curr Drug Targets; 2013 Nov; 14(12):1433-43. PubMed ID: 23980911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid imprints gut-homing specificity on T cells.
    Iwata M; Hirakiyama A; Eshima Y; Kagechika H; Kato C; Song SY
    Immunity; 2004 Oct; 21(4):527-38. PubMed ID: 15485630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
    Zundler S; Neurath MF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S19-28. PubMed ID: 26458165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases.
    Saruta M; Papadakis KA
    Gastroenterol Clin North Am; 2014 Sep; 43(3):581-601. PubMed ID: 25110260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies.
    Dotan I; Allez M; Danese S; Keir M; Tole S; McBride J
    Med Res Rev; 2020 Jan; 40(1):245-262. PubMed ID: 31215680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR9 and inflammatory bowel disease.
    Koenecke C; Förster R
    Expert Opin Ther Targets; 2009 Mar; 13(3):297-306. PubMed ID: 19236152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases.
    Danese S; Panés J
    Gastroenterology; 2014 Nov; 147(5):981-9. PubMed ID: 25220794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homing of immune cells: role in homeostasis and intestinal inflammation.
    Hart AL; Ng SC; Mann E; Al-Hassi HO; Bernardo D; Knight SC
    Inflamm Bowel Dis; 2010 Nov; 16(11):1969-77. PubMed ID: 20848507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases.
    Smids C; Horjus Talabur Horje CS; van Wijk F; van Lochem EG
    J Crohns Colitis; 2017 Apr; 11(4):500-508. PubMed ID: 27660340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of αEβ7 integrin suppresses accumulation of CD8
    Zundler S; Schillinger D; Fischer A; Atreya R; López-Posadas R; Watson A; Neufert C; Atreya I; Neurath MF
    Gut; 2017 Nov; 66(11):1936-1948. PubMed ID: 27543429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.